Medline (MDLN) Non-Current Deferred Tax Liability (2025 - 2026)

Medline's (MDLN) quarterly Non-Current Deferred Tax Liability came in at $4.0 billion in Q1 2026, up 13.18% on a QoQ basis from $3.5 billion in Q4 2025.

Medline (MDLN) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

Medline (MDLN) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $4.0 billion in Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $4.0 billion in Q1 2026; TTM through Mar 2026 was $4.0 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $3.5 billion, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability for Q1 2026 stood at $4.0 billion, up from $3.5 billion in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for MDLN reached as high as $4.0 billion in Q1 2026 and fell as low as $3.5 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 4.01 Bn
Mar 28, 2026 4.01 Bn
Dec 31, 2025 3.54 Bn
Dec 31, 2025 3.54 Bn